Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 11B1 (CYP11B1), also known as steroid 11β-hydroxylase, is a mitochondrial enzyme that belongs to the cytochrome P450 superfamily. It plays a critical role in the biosynthesis of glucocorticoids, particularly cortisol and corticosterone, within the adrenal cortex. It catalyzes the final steps in cortisol and corticosterone synthesis: Converts 11-deoxycortisol to cortisol and converts 11-deoxycorticosterone to corticosterone. Mutations in CYP11B1 cause congenital adrenal hyperplasia (CAH) due to 11β-hydroxylase deficiency, leading to excess androgen production and virilization. Overactivity or dysregulation can contribute to Cushing's disease through excessive cortisol production. The closest paralog is CYP11B2 (aldosterone synthase), which primarily produces aldosterone rather than cortisol/corticosterone but shares significant sequence similarity and overlapping substrate specificity.
Inhibition of 11β-hydroxylation of steroid substrates
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 11B1 (None).